We describe the fate of the polyene antibiotic amphotericin B (AmB) after its interaction with Chinese hamster ovary (CHO) cells. The global uptake of AmB by these cells was measured at 37°C after a 1-h incubation in the presence of 5% fetal bovine serum. It increased with the total concentration of drug and reached a plateau of approximately 1 nmollmg of cell protein for an external concentration of 25 ,uM. The same experiment performed at 5°C revealed a drastic decrease in uptake. The distribution of the drug among plasma membranes, endosomes, and lysosomes was then investigated after the separation of the postnuclear fractions by a Percoll gradient. After a 10-min incubation, AmB was found only in the plasma membrane fraction, regardless of the drug concentrations used (5 to 100 ,uM). After 60 min, at low drug concentrations (5 and 10 ,uM) AmB was found to be incorporated mainly in plasma and lysosomal fractions. At high concentrations (50 ,uM) AmB accumulated in endosomal fractions and plasma membranes. At intermediate concentrations (25 ,uM) AmB was distributed among the three fractions. When the same experiment was carried out at 5°C, AmB was associated only with the plasma membrane even after 60 mi, which was consistent with the absence of the endocytotic process at low temperature. The effect of AmB on the endocytic process resulted in the increased uptake of sulforhodamine B, a fluid-phase marker of endocytosis, as well as by the accumulation of sulforhodamine in spots scattered in the cytoplasms of AmB-treated cells, in contrast to the accumulation around the nuclei observed in the control cells. These results are interpreted as indicating that AmB is internalized by the cells through endocytosis and that high concentrations of the drug block the fusion between endosomes and/or the fusion between endosomes and lysosomes.
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Amphotericin B (AmB), a polyene macrolide antibiotic, is well known for its activity against cells containing sterols in their plasma membranes. It is therefore a drug of choice for the treatment of fungal infections (fungal cells have ergosterolcontaining membranes), but it also causes toxic side effects (mammalian cells have cholesterol-containing membranes). Many studies devoted to the elucidation of the polyene's mechanism of action have shown that AmB acts primarily at the membrane level, e.g., the alteration of plasma membrane permeability because of the formation of transmembrane channels (for reviews, see references 6 and 10), inhibition of H+ ATPase in fungal cells (31) and Na+/K+ ATPase in erythrocytes (33) , and the enhancement of oxidative damage (9) . However, the mechanism at the origin of the cell killing has not yet been determined. Furthermore, some observations cannot be explained by a mechanism concerning only the membrane level. For example, at sublethal doses, AmB shows a stimulatory effect and acts synergistically with other antifungal agents and antitumor compounds without inducing K+ channels (32) .
The implication of the internalization of AmB has not been addressed so far; in particular, because of its large molecular size, the drug is assumed not to cross the plasma membrane barrier by flip-flop. It should be noted, however, that binding of AmB to internal membranes has already been considered to explain the biphasic quenching of the membrane probe 1-(4-[trimethylammonio]phenyl)-6-phenylhexa-1,3,5-triene, p-toluenesulfonate by AmB (17) . No investigation concerning the internalization of the antibiotic and the effect of AmB on endocytosis has been carried out. Briefly, endocytosis is the constitutive cellular process, specific or nonspecific, used for the sequestration and internalization of both soluble and membrane-bound materials by invagination of the plasma membrane (3, 4, 24) . The newly formed intracellular vesicles (endosomes) may ultimately fuse with lysosomes where the ingested material is degraded enzymatically.
In the study described here our aim was to analyze the mechanism of toxicity of AmB by examining whether AmB can be internalized after it is bound to the surfaces of mammalian cells. If this is the case, we wanted to determine whether endocytosis could be at the origin of this observation and whether the endocytic process could be affected by AmB. We chose Chinese hamster ovary (CHO) cells as an example of mammalian cells, in particular because they contain constitutive low-density lipoprotein (LDL) receptors (15) .
MATERIALS AND METHODS
Cell culture and cell preparation. CHO-Kl cells were grown in monolayer in a humidifier incubator (5% CO2) at 37°C in a 25-cm2 flask (Nunc) containing 10 ml of F12-S (Ham's F12; Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 5% fetal bovine serum (FBS; Sigma), L-glutamine, penicillin, and streptomycin (Gibco). Cells were trypsinized for 5 min at 25°C with 0.025% trypsin, centrifuged, rinsed with F12-S medium, and counted. Cells (5 x 106) were then plated on order to localize the subcellular components separated by a Percoll gradient, CHO cells were labeled with fluorescence dyes as follows prior to the subcellular fractionation.
(i) Plasma membranes. Cells were incubated with tetramethylrhodamine isothiocyanate-conjugated concanavalin A (TRITC-Con A; Vector Laboratory Inc., Burlingame, Calif.) at 2 mg/ml for 90 min at 4°C and were then extensively washed with HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered minimum essential medium (HMEM; Nissui) containing 5% FBS, rinsed with sucrose homogenizing buffer (SHB; 250 mM sucrose, 1 mM EDTA, 10 mM HEPES [pH 7.2]), and homogenized in 2 ml of SHB by 20 strokes in a 2-ml tight-fitting Dounce tissue grinder. The completeness of homogenization was examined by phase-contrast microscopy. The homogenates were centrifuged (1,000 x g, 10 min) to obtain a postnuclear supematant.
(ii) Endosomes. Labeling of endosomes was achieved by a previously described procedure (21) . Cells were incubated with sulforhodamine B (SRh; Eastman Kodak) at 5 mg/ml for 10 min at 37°C and were then extensively washed with a HEPESbuffered calcium-and magnesium-free solution (HCMF; 137 mM NaCl, 5.4 mM KCl, 10 mM glucose, 10 mM HEPES [pH 7.4]), rinsed with SHB, and homogenized as described above.
(iii) Lysosomes. Labeling of lysosomes was achieved by a previously described procedure (25, 27) . Cells were incubated with SRh at 5 mg/ml for 10 min at 37°C, extensively washed with HCMF, and chased for 15 to 30 min at 37°C in fresh F12-S medium. After the incubation, cells were rinsed with HCMF and then SHB and were homogenized as described above.
Subcellular fractionation by a Percoll density gradient.
Postnuclear supernatants (2 ml) were mixed with 6.1 ml of 26% Percoll (Pharmacia Fine Chemicals) in SHB and layered on a 1-ml cushion of 60% sucrose. The tubes were centrifuged in a Beckman 50 Ti rotor (Beckman Instruments Inc., Palo Alto, Calif.) at 26,000 rpm for 45 min at 4°C. Twenty fractions were collected from the gradients, starting from the bottom of the tube. The formation of a gradient was verified in all experiments by using density marker beads (Pharmacia Fine Chemicals) under identical conditions. The fluorescences of tetramethylrhodamine and SRh were measured at excitation wavelengths (Xex) of 555 and 565 nm and emission wavelengths (Aem) of 575 and 580 nm, respectively. All fluorescence measurements were carried out in the presence of 1 to 2% of Triton X-100 (TX100).
Treatment of cells by AmB and determination of AmB uptake. For all the experiments AmB (a gift from Squibb France) was freshly prepared from a stock solution in dimethyl sulfoxide (DMSO) by dilution so that a final solution contained less than 1% DMSO in the medium. AmB was added to the cells at concentrations ranging from 0.25 to 100 ,uM, that is, at concentrations necessary for the inducement of K+ leakage and cell toxicity. Incubation times were 10, 30, and 60 min. AmB was preincubated for 30 min at 37°C in F12-S prior to contact with the cells, which allowed its binding to serum proteins if they were present. AmB has already been shown to bind to serum components (8) .
The cells, which were plated at 3 x 105/ml on the day before the experiments, were then incubated after removal of the old medium in a humidifier incubator at 37°C in the presence of antibiotic at the desired concentration and for the desired time. The cells were then rapidly cooled down and washed four times with HCMF. Some experiments were carried out in parallel at 5°C to evaluate adsorption and membrane interaction since no endocytosis occurs at less than 18°C (4). Cellular viability was tested by the following procedures. Aliquots of cells treated with TX100 or removed with a cell scraper (see below) were used for the protein assay by Lowry's procedure, which was based on Peterson's (26) modification. In the first case, a standard curve was obtained in the presence of 1% TX100. For the studies with cell suspensions, measurement of the cell concentration was obtained by counting cells under a phase-contrast microscope.
For the determination of AmB uptake, two procedures were applied.
(i) Determination of the global uptake of AmB. Cells were treated with 1% TX100 and were kept at 37°C for 20 min to complete total cell destruction. Polyene antibiotic concentrations were measured by absorption by using a UV-visible Hitachi U-3200 spectrophotometer. In the presence of TX100, AmB was totally solubilized and presented spectra characteristic of monomeric AmB (6) , with a molar extinction coefficient £ at 413 nm of 105 mol-cm-'. Under the conditions of the study, no trace of aggregated AmB (absorption peak at about 340 nm) was detected and the increase in absorption varied linearly with the concentration. Proteins were shown not to interfere with the assay. We could detect AmB at concentrations of as low as 0.02 ,uM in 0.5 ml. The results were reproducible, with a variation of S to 10% from one sample to the other.
(ii) Determination of AmB concentrations in subcellular fractions. Cells were carefully removed from the dishes with a cell scraper, homogenized, and centrifuged to obtain a postnuclear supernatant. The total bound AmB estimated in this way is essentially equivalent to the sum of the AmB present in the postnuclear supernatants and the pellets (resuspended in 2 ml). However, the amount of AmB found in the pellets was negligibly small. The concentration of AmB was determined spectrophotometrically as described above. To correct the background absorption mainly owing to the light scattering of Percoll, measurements were performed against control samples containing postnuclear fractions of nontreated cells. The amount distributed in each subcellular fraction was presented as the percentage of the total AmB bound to cells determined from the integrated areas.
Effect of AmB on intracellular K+ and incorporation of the fluid-phase uptake marker SRh. The exact protocol for determinations of the effect of AmB on intracellular K+ and the incorporation of the fluid-phase uptake marker SRh was different from that of the former experiments in order to be able to measure all of the parameters with the same batch of cells. Some quantitative differences may have arisen from this experimental modification. Cells were trypsinized, counted, resuspended at 4 x 105/ml in fresh F12-S, and allowed to recover for at least 1 h at 37°C. AmB was added to F12-S in sterile tubes at final concentrations of between 0.25 and 100 p,M, and the mixtures were incubated at 37°C for 30 min. Cells were then added to the tubes at a final concentration of 2 x 105/ml, equivalent to the concentration used in the previous experiments with 143-cm2 dishes. SRh at a concentration of 1 mg/ml was added simultaneously. The incubation was stopped after the desired time by chilling the cells, which were then rinsed five times with HCMF and twice with SHB and resuspended in SHB. A portion of the suspension was taken for counting the cell concentration, which was determined by counting the cells under a phase-contrast microscope (Zeiss). TX100 was added to the suspension at a final concentration of 2% to solubilize the cells for the following spectrophotometric measurements. The fluorescence of SRh was measured at an Fluorescence microscopy of SRh-labeled cells. Cells (3 x 105) were plated on sterile coverslips in 8.5-cm2 petri dishes and were grown for 24 h in F12-S. AmB was added to prewarmed sterile F12-S, incubated for 30 min at 37°C, and added to the dishes after aspiration of the old medium. SRh was simultaneously added at a concentration of 1 mg/ml. After the cells were kept at 37°C for the desired time (10, 20, or 30 min), the medium was removed and the cells were rapidly cooled by adding ice-cold HCMF and placing the dishes on ice. The cells were then rinsed three times with ice-cold HCMF and three times with HMEM containing 5% FBS. Specimens were observed with a Zeiss IM-35 microscope equipped with epifluorescence optics and a phase-contrast objective (X40 objective; Planapo n.a. 1.0). Neopan 400 Presto film (Fuji Photo) was used, and the photographs were developed at 3200 ASA.
RESULTS
AmB toxicity and global uptake. Before investigating the incorporation of AmB into the subcellular fractions, the possible toxic effect of AmB on CHO cells at concentrations of between 5 and 100 ,uM was considered. We found that cells were less sensitive to the toxicity of AmB, especially at its high concentration, if AmB was preincubated with 10% serumcontaining medium for 30 min at 37°C before addition to the cell dishes than if it was added directly. Under these conditions, cells began to be killed at 10 ,uM AmB, as measured by protein concentration measurements. For example, the proportion of cells killed was 20% with 50 p.M AmB. By microscopy examination, blebs were observed on some cells after 1 h at drug concentrations greater than 25 ,uM. These cells peeled off from the dishes after 2 to 3 h. It should be noted that in the following experiments the cells not firmly adherent to the dishes were washed out during the extensive rinses performed before the subcellular fractionation. AmB uptake by cells increased with the AmB concentration in the medium. A decrease in the temperature of the incubation medium, from 37 to 5°C, drastically diminished this uptake (Fig. 1) .
Distribution of AmB among plasma membranes, endosomes, and lysosomes. Fractionation of postnuclear fractions was first performed in the absence of AmB by a Percoll gradient. As shown in Fig. 2 , lysosomes were found at the bottom of the gradient, in fractions 2 to 7, endosomes were found between fractions 8 and 16, with a maximum concentration around fractions 12 and 13, and plasma membranes were present as a sharp peak in fractions 14 and 15.
When the cells were treated with 5, 10, 25, 50, and 100 ,uM AmB at 37°C, AmB was mainly found in the plasma membrane fraction after a 10-min incubation, regardless of the concentration of drug used (Fig. 3) . Slight trailings of the peaks around fractions 9 to 12 are indicative of a small accumulation of AmB in the endosomal fractions. After 30 min of incubation, however, different distribution profiles of AmB were observed, depending on the concentration of drug added. At low concentrations of AmB (5 and 10 ,uM), considerable amounts of the polyene were found in the lysosome fractions; in addition, some was found in the endosome fractions; 56, 24 , and 20% bound AmB was found in the plasma membrane, endosome, and lysosome fractions, respectively, when the cells were treated with 5 and 10 ,uM AmB (data not shown). At high concentrations (25, 50 , and 100 ,uM) of AmB, the main peak of AmB was shifted to higher-density fractions and broadened compared with that observed with a 10-min incubation, indicating an accumulation of the polyene in endosomes but not much accumulation in lysosomes. In fact, 55, 36, and 9% of the total AmB was found in the plasma membrane, endosome, and lysosome fractions, respectively, at 50 p,M AmB (data not shown). After 60 min of incubation (Fig. 4) , the concentration dependence of the AmB distribution became more conspicuous. At 5 ,uM a majority of the AmB was still found in the plasma membrane fractions, with the remaining found in the endosomal and lysosomal fractions. A similar distribution profile was observed at 10 ,uM (data not shown). However, at 25 ,uM there were two major peaks of AmB, representing 42 and 49% of the total in the plasma membrane and endosome fractions, respectively. Accordingly, the contribution of AmB in the lysosome fraction was only 9%. At 50 ,uM most much lower concentrations of AmB; i.e., the treated cells started to release K+ at concentrations as low as 1 puM AmB, and only 10% of the cellular K+ remained at 5 pM AmB (Fig.  5) , indicating that the endocytosis caused by AmB occurs even after the formation of the polyene channel. Similar results were observed after a 30-min incubation with AmB. It may be noted that there was no significant interference caused by AmB per se in the distribution of SRh, probably because of the high degree of solubility of SRh. Actually, when tetramethylrhodamine isothiocyanate-conjugated dextran, another fluidphase marker for endosome, was used in place of SRh, the formation of floccules was observed.
Additionally, the intracellular distribution of SRh in CHO cells was observed by epifluorescence microscopy. In control cells, a small number of fluorescent spots was observed around the nucleus, which indicated an accumulation of SRh in the lysosomes (Fig. 6C and D) . When the cells were treated with AmB at 50 F.M, the fluorescence intensity of the SRh spots was greater and large numbers of spots were found scattered over the cytoplasm (Fig. 6A and B) , which suggested an accumulation of SRh in the endosomes.
DISCUSSION
The in vivo toxicity of AmB results partly from direct interactions with mammalian cells, since the drug has the same type of effect on mammalian and fungal cells. In vitro studies of its toxicity against mammalian cells help us to better understand the mechanisms involved in its in vivo toxicity. In the present study we addressed the question of the possible internalization of AmB as an alternative to other mechanisms of action that have been studied more closely. There is no reason why AmB would not be internalized, and we have shown, for the first time, that at 37°C AmB is indeed internal- tion does not seem to be directly related to the formation of AmB channels in the plasma membrane since the amount of AmB required for inhibition was much greater than that which causes K+ leakage from the plasma membrane (Fig. 5) . It should be emphasized that if endocytosis proceeded normally, there would be no accumulation of endosomes; i.e., most endosomes would be converted into lysosomes within 30 min at 37°C, as evidenced by the distribution of SRh in CHO cells in the absence of AmB.
On the other hand, the AmB molecules incorporated by pinocytosis or adsorptive endocytosis are bound to any hydrophobic macromolecular components in serum and are easily integrated into the endosomal membrane, which results in an inhibition of the fusion processes among endosomes and/or endosomes-lysosomes during the pinocytic process.
It has been established that internalized macromolecules appear sequentially in two distinct subpopulations of endosomes, early and late endosomes, during the transport toward lysosomes (for a review, see reference 16). These subpopulations of endosomes are different in morphology, structure, and functional properties. For example, the receptors are recycled to the plasma membrane by early endosomes, but the incorporated ligands are transported to lysosomes by late endosomes. The endosomal membrane is extremely permeable to protons, and the pH of endosomes is regulated by an ATPdependent proton pump (13) as well as by an Na+/K+ ATPase which generates an interior positive membrane potential, resulting in the inhibition of an excessive acidification of the endosomes (11, 14) . This inhibition is found only in early endosomes. The disorder of plasma membrane permeability by AmB (6) and the inhibitory effect on the Na+/K+ ATPase of erythrocytes (33) are well documented. Therefore, it is likely that similar activities may develop on the endosomal membrane, resulting in a drastic change in the endosomal pH immediately after the initiation of endocytosis of the drug, probably at the early endosome stage. The consequence of the pH change would be an inhibition of endosome maturation and subsequent fusion to lysosomes (16, 30) . For isolated lysosomes, it has been shown that increasing AmB concentrations induce the release of proteases and then inhibit their activity (20) . It should be noted that the effects of the substances that affect the physical properties of the membrane on subcellular organelles in intact cells are quite different from those on isolated organelles. For example, ionophores and weak bases do not inhibit fusion in a cell-free system, suggesting that a pH gradient across the vesicle membrane is not crucial for the fusion process (7) .
An interesting observation of the present study is that the increase in SRh uptake occurred even after 90% of the intracellular K+ had leaked out. This increase mainly represented the accumulation of AmB in endosomes, as evidenced by Percoll gradient fractionation as well as by observations under the microscope. It has been shown in 3T3 Li fibroblasts (12, 22) that receptor-mediated endocytosis is inhibited by depletion of intracellular K+. However, a recent study on the endocytosis of hyaluronan in rat Kupffer cells demonstrates that K+ depletion does not affect the internalization of the fluid-phase marker (1).
Moreover, low temperature (18°C) rules out the fusion of endosomes (28, 29) , and the repartition of fluorescent tracers in cells is then equivalent to the repartition observed in the presence of AmB, supporting the fact that in the presence of the polyene the endocytic process is blocked at one step.
The presence of a certain amount of serum in the growth medium changed the dose-response curve of the action of AmB. This has already been reported with a kidney epithelial ANTIMICROB. AGENTS CHEMOTHER.
cell culture (19) . The serum in the incubation medium may have modified the mechanism of action of AmB and brought it closer to that which actually operates in vivo. Indeed, AmB binds to human serum components, in particular, to lipoproteins and albumin (8) . After a 1-h incubation at 37°C, more than 75% of the AmB bound to lipoproteins was recovered in the high-density lipoprotein fraction (34) . It can be assumed that, as with AmB liposomal formulations, bound AmB is not directly active on plasma membranes and does not induce permeability changes. Indeed, a concentration of 2 x 10' M was necessary to induce K+ effiux from erythrocytes incubated in whole blood (5), while a concentration of 5 x 10-7 M was sufficient to induce 50% leakage after a 1-h incubation in phosphate-buffered saline. In the presence of serum it is quite possible that the mechanism of endocytosis grows in importance and may be at the origin of the cellular toxicity, with lipid peroxidation not being neglected. Under the experimental conditions of the present study, with the serum concentration being 5%, we had a situation intermediate between that which occurs in vivo and that which is obtained in buffer. LDL-bound AmB could enter the cells by a mechanism of specific endocytosis through the LDL receptors. Indeed, LDLs of a 1/12 AmB-LDL complex were found to be processed in human fibroblasts by the LDL receptor pathway to the same extent as LDLs in the absence of AmB (23) . In serum we saw that less than 25% of the lipoprotein-bound AmB is recovered in the LDL fraction. Specific endocytosis would therefore be relatively unimportant. In contrast, if an excess of the AmB-LDL complex is administered, as was done with rabbits (18), the toxicity is increased. Our proposal would also explain the proposed correlation between the inhibition of the AmBlipoprotein interaction and the decreased toxicity for mice of AmB bound to phospholipid-surfactant mixed micelles or lauryl sucrose (2) . Our study also raises the question of whether the endocytosis of AmB also exists for fungal cells and, if so, by which mechanism.
